Studies have found that the RAB5 subfamily (including RAB5, RAB21, RAB22A, and RAB22B) is primarily involved in the endocytosis, transport, and metabolism of growth factor receptors and may thus be associated with cancer progression (6–8). This evidence concerns the gene RAB22A and cancer.